Cognitive enhancers for the treatment of ADHD
Open accessThe DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Abstract
Attention-deficit hyperactivity disorder (ADHD) is associated with multiple cognition-related phenotypic features in both children and adults. This review aims to clarify the role of cognition in ADHD and how prevailing treatments, which are often highly effective at reducing the clinical symptoms of the disorder, fare in modulating ADHD-related cognitive processes. First, we consider how the broad construct of cognition can be conceptualized in the context of ADHD. Second, we review the available evidence for how a range of both pharmacological and non-pharmacological interventions have fared with respect to enhancing cognition in individuals affected by this pervasive disorder. Findings from the literature suggest that the effects across a broad range of pharmacological and non-pharmacological interventions on the characteristic symptoms of ADHD can be distinguished from their effects on cognitive impairments. As such the direct clinical relevance of cognition enhancing effects of different interventions is somewhat limited. Recommendations for future research are discussed, including the identification of cognition-related end ophenotypes, the refinement of the ADHD clinical phenotype, and studying the difference between acute and chronic treatment regimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886 · cited 1×
“Attention deficit hyperactivity disorder (ADHD) is one of the most common psychiatric disorders, affecting approximately 8–9% of school-aged children and 4–5% of adults (Froehlich et al., 2007; Kessler et al., 2006; Visser et al., 2007).”
Background(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Executive functions and developmental psychopathology.
Pennington, B. F., & Ozonoff, S. (1996) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1996.tb01380.x · Cited by 3,150 · cited 4×
“…that ADHD is due to deficits in overall executive functions (EFs) or specific aspects of EF such as response inhibition (Barkley, 1997; Nigg, 2001; Pennington and Ozonoff, 1996), aversion to delay (Sonuga-Barke, 2003; Sonuga-Barke et al., 1992), difficulty modulating behavior in response to…”
BackgroundInfluentialComputerized training of working memory in children with ADHD – a randomized, controlled trial
Klingberg, T., Fernell, E., Olesen, P. J., Johnson, M., Gustafsson, P., Dahlström, K., Gillberg, C. G., Forssberg, H., & Westerberg, H. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200502000-00010 · Cited by 1,949 · cited 2×
“Subjects in the active intervention condition demonstrated improvements on trained and untrained measures of working memory, and also showed improved response inhibition and reductions in parent-rated inattentive symptoms of ADHD that were durable at follow-up assessments (Klingberg et al., 2005).”
BackgroundNeuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes
Castellanos, F. X., & Tannock, R. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn896 · Cited by 1,827 · cited 1×
“Another theoretical account of reaction time abnormalities suggests that greater response variability could result fromdysfunction in short-duration timingmechanisms that are largely mediated by cerebellar circuits (Castellanos and Tannock, 2002; Toplak and Tannock, 2005).”
BackgroundPliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
The functions of the orbitofrontal cortex
Rolls, E. T. (2004) · Brain and Cognition · doi:10.1016/s0278-2626(03)00277-x · Cited by 1,327
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320 · cited 1×
“where theymediate reward and reinforcement (Picciotto et al., 1998).”
Increased prefrontal and parietal activity after training of working memory
Olesen, P. J., Westerberg, H., & Klingberg, T. (2004) · Nature Neuroscience · doi:10.1038/nn1165 · Cited by 1,317 · cited 1×
“This same training protocol was shown to produce increases in brain activation (Olesen et al., 2004) and changes in the density of prefrontal and parietal dopamine D1 receptor binding potential, indicating neural plasticity that arises as a result of the training (McNab et al.”
BackgroundNot All Executive Functions Are Related to Intelligence
Friedman, N. P., Miyake, A., Corley, R. P., Young, S. E., DeFries, J. C., & Hewitt, J. K. (2006) · Psychological Science · doi:10.1111/j.1467-9280.2006.01681.x · Cited by 1,293
Cited by
Abnormal Functional Connectivity in Children with Attention-Deficit/Hyperactivity Disorder
Tomasi, D., & Volkow, N. D. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.11.003 · Cited by 363
Stress-induced cognitive dysfunction: hormone-neurotransmitter interactions in the prefrontal cortex
Shansky, R. M., & Lipps, J. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00123 · Cited by 205
“Numerous mental illnesses—including Major Depressive Disorder, PTSD, Schizophrenia, and Attention Deficit/Hyperactivity Disorder [ADHD (Arnsten, 2007)]—are characterized by PFC dysfunction, and the pathways elucidated by the animal research described here are currently being targeted in pharmacological therapies.”
BackgroundBari, A., & Aston-Jones, G. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.020 · Cited by 85
Wong, C. G., & Stevens, M. C. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.11.011 · Cited by 80
The Effect of Systemic Chemotherapy on Neurogenesis, Plasticity and Memory
Wigmore, P. (2012) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2012_235 · Cited by 66
Hutson, P. H., Tarazi, F. I., Madhoo, M., Slawecki, C., & Patkar, A. A. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.03.005 · Cited by 31
“However, the data have been relatively inconsistent and the effective doses can vary greatly (Bidwell et al., 2011; Swanson et al., 2011).”
BackgroundDisrupted reinforcement learning during post-error slowing in ADHD
Chevrier, A., Bhaijiwala, M., Lipszyc, J., Cheyne, D., Graham, S., & Schachar, R. (2019) · PLOS ONE · doi:10.1371/journal.pone.0206780 · Cited by 21
“, 2013), interact with DA via direct and indirect pathways (Boureau and Dayan, 2011; Yu and Dayan, 2003), and exhibit altered functioning in ADHD (Bidwell et al., 2011).”
BackgroundEfficacy of online intervention for ADHD: a meta-analysis and systematic review
Shou, S., Xiu, S., Li, Y., Zhang, N., Yu, J., Ding, J., & Wang, J. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.854810 · Cited by 20
Stimulants, cognition and ADHD
Baroni, A., & Castellanos, F. X. (2015) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2015.04.010 · Cited by 14
“Cognitive effects of chronic stimulants Although clinicians expect most patients with ADHD to take stimulants on a nearly daily basis for months to years, the few studies that have examined long-term stimulant effects on cognition [27] have found limited improvements [20,24,28–30].”
BackgroundThe effects of the prodrug Vyvanse on spatial working memory and adiposity in rats
Ekstrand, E., Murphy, H. M., & Wideman, C. H. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172765 · Cited by 12
Metadata
- Authors
- Bidwell, L. C., McClernon, F. J., & Kollins, S. H.
- Venue
- Pharmacology Biochemistry and Behavior
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 99
- Issue
- 2
- Pages
- 262-274
- ISSN
- 0091-3057 (ISSN-L)
- OpenAlex
- W2101973336
- Cited by
- 102
- References
- 86
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.